Oral Vitamin D Treatment for the Prevention of Hepatocellular Carcinoma
Status:
Not yet recruiting
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether vitamin D is effective in the prevention of
hepatocellular carcinoma in those patients with chronic hepatitis B.
Phase:
Phase 4
Details
Lead Sponsor:
Third Affiliated Hospital, Sun Yat-Sen University
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins